CORONAVIRUS
Clinical trials for CORONAVIRUS explained in plain language.
Never miss a new study
Get alerted when new CORONAVIRUS trials appear
Sign up with your email to follow new studies for CORONAVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Oxford COVID-19 vaccine trial shows promise in over 10,000 volunteers
⭐️ VACCINE ⭐️ CompletedThis study tested the Oxford COVID-19 vaccine (ChAdOx1 nCoV-19) in over 10,000 healthy adults aged 18 and older. The goal was to see if the vaccine could prevent symptomatic COVID-19 and to check for any serious side effects. Participants received the vaccine and were monitored f…
Matched conditions: CORONAVIRUS
Phase: PHASE2, PHASE3 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:39 UTC
-
Oxford vaccine trial shows promise against COVID-19
⭐️ VACCINE ⭐️ CompletedThis study tested a new COVID-19 vaccine called ChAdOx1 nCoV-19 in over 1,000 healthy adults aged 18-55 in the UK. The goal was to see if the vaccine is safe and can prevent symptomatic COVID-19. Participants received the vaccine or a placebo, and researchers tracked infections a…
Matched conditions: CORONAVIRUS
Phase: PHASE1, PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 08:33 UTC
-
Can these drugs stop COVID pneumonia in its tracks?
Disease control CompletedThis study tested two drugs, ruxolitinib and fostamatinib, in hospitalized adults with mild to moderate COVID-19 pneumonia. The goal was to see if either drug could prevent the pneumonia from becoming severe, requiring intensive breathing support or causing death. Participants re…
Matched conditions: CORONAVIRUS
Phase: PHASE1, PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated May 26, 2026 08:32 UTC
-
Can a simple gas save COVID-19 patients on ventilators?
Disease control CompletedThis study tested whether breathing in nitric oxide gas helps COVID-19 patients on ventilators get more oxygen into their blood. The trial included 200 adults in intensive care units. Researchers measured changes in oxygen levels after 48 hours of treatment.
Matched conditions: CORONAVIRUS
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Can a simple walk help cancer survivors heal from COVID?
Symptom relief CompletedThis study tested whether a 30-week walking program is safe for cancer patients who were hospitalized for COVID-19. Only 3 people took part, and the goal was to see if the exercise caused any serious side effects. The walking plan was adjusted to each person's fitness level.
Matched conditions: CORONAVIRUS
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated May 22, 2026 14:03 UTC
-
Scientists track COVID-19 in 199 patients to uncover key patterns
Knowledge-focused CompletedThis study watched 199 adults hospitalized with COVID-19 to learn more about the disease. Researchers collected information on patient backgrounds, treatments used, and how the illness progressed over time. The goal was to answer important questions about COVID-19 that were still…
Matched conditions: CORONAVIRUS
Sponsor: Target PharmaSolutions, Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 08:41 UTC
-
Blood tests may predict COVID-19 worsening in ER patients
Knowledge-focused CompletedThis study aimed to find simple blood markers that could predict if a person with suspected COVID-19 in the emergency room would later get sicker. Researchers followed 373 patients to see if routine lab tests could forecast worsening. The goal was to help hospitals better allocat…
Matched conditions: CORONAVIRUS
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 26, 2026 08:31 UTC
-
Healthcare workers under the microscope: COVID-19 transmission study completed
Knowledge-focused CompletedThis study followed over 800 healthcare workers and non-healthcare workers for several years to understand how SARS-CoV-2 spreads and who gets sicker. Researchers collected swabs, blood, and saliva samples along with survey data. The goal was to identify risk factors for infectio…
Matched conditions: CORONAVIRUS
Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC